Glaxosmithkline Plc on Wednesday posted an 27 percent rise in profit after tax for the third quarter of 2004, a result at the bottom of analysts' expectations for Europe's biggest pharmaceutical company.
Glaxosmithkline posts increase in third quarter earnings sales.